Kate Bingham appointed Chair of UK Vaccine Taskforce
Kate Bingham has been appointed Chair of the UK’s Vaccine Taskforce – the group set up by the Government’s Chief Scientific Adviser, Deputy Chief...
NHS roadmap to safely bring back routine operations during COVID-19
Health leaders have set out a series of measures to help local hospitals plan to increase routine operations and treatment, while keeping the necessary...
BIVDA comments on Roche COVID-19 antibody test authorisation
The British In Vitro Diagnostics Association (BIVDA) has commented on the Roche COVID-19 antibody test authorisation by Public Health England. BIVDA is delighted to see...
New partnership to sequence human genomes to study genetics and coronavirus
Thousands of patients severely ill with COVID-19 will have their genetic code studied to help scientists understand any link between genetics and coronavirus. The major...
Senzer launches Critical Care Division for anti-viral COVID-19 treatments
Senzer Pharmaceuticals, a UK company involved in the development, manufacture and licencing of pioneering respiratory products for pharmaceutical formulations, has launched a Critical Care...
COVID-19 drugs trial rolled out across UK homes and communities
A UK COVID-19 drugs trial – testing whether low-risk treatment in the community can help people at higher risk of complications from COVID-19 to...
How effective data strategies in labs are increasing the throughput of lifesaving drugs
Pietro Forgione of IDBS explains how effective data strategies in labs are increasing the throughput of lifesaving drugs. From R&D contract organisations to large pharmaceutical...
Race to develop sustainable COVID-19 vaccine delivery
Scientists are launching a major new research project in India that will help to engineer an efficient and sustainable delivery mechanism – ready to...
Closed Loop Medicine partners with US trial to find COVID-19 and hypertension link
Closed Loop Medicine, a UK therapeutics company, will launch clinical trials in the US to find links between Covid-19 and hypertension. The Cambridge-based company is...
New COVID-19 guideline on acute kidney injury
The National Institute for Heath and Care Excellence has published a new COVID-19 rapid guideline on acute kidney injury (AKI). The guideline aims to help...
Latest articles
Reducing time to market for new COVID-19 vaccines
With the target set to offer a COVID-19 vaccine to a further 17.7 million people in the next five priority groups - including all...
NHS gives women Human Papillomavirus Virus (HPV) home testing kits
NHS England has announced that more than 31,000 women will be offered kits to carry out HPV self-sampling in the privacy and convenience of...
Tribunal upholds CMA decision on pharma collusion and £1.2m fine
The Competition Appeal Tribunal has upheld the Competition and Markets Authority (CMA)’s finding that pharmaceutical firm Lexon broke competition law, dismissing Lexon’s appeal. Last year,...
Popular articles
Study shows anti-parasitic drug ivermectin kills coronavirus within 48 hours
A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) with the Peter Doherty Institute of Infection and Immunity (Doherty Institute), a joint...
New Normal, New Thinking: Life Post COVID-19
New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
NHS prescription charge to increase from 1 April 2021
The NHS prescription charge will increase to £9.35 per prescription item from 1 April 2021 in England, according to the Pharmaceutical Services Negotiating Committee...
NHS gives women Human Papillomavirus Virus (HPV) home testing kits
NHS England has announced that more than 31,000 women will be offered kits to carry out HPV self-sampling in the privacy and convenience of...
Tribunal upholds CMA decision on pharma collusion and £1.2m fine
The Competition Appeal Tribunal has upheld the Competition and Markets Authority (CMA)’s finding that pharmaceutical firm Lexon broke competition law, dismissing Lexon’s appeal. Last year,...